Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Ondas Inc. Common Stock (ONDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Ondas Inc. Common Stock — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Ondas Inc. Common Stock trades at $5.96 (market cap $3.58B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.4× Ondas Inc. Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Ondas Inc. Common Stock for 2 Days on average.
| HNGE | ONDS | |
|---|---|---|
Market Cap | $8.47B | $3.58B |
Volume | 1,624,526 | 67,110,314 |
Sector | Health | Technology |
52-Week High | $105.14 | $14.01 |
52-Week Low | $31.17 | $5.25 |
Typical Hold Time | 0 Days | 2 Days |
Enterprise Value | $8.09B | $2.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
ONDS trades at $6.71, up 0.6% on the day, amid mixed technical signals with a bearish moving average trend but oversold RSI levels. The company reported a net loss of $132.02M for 2025 but shows a projected turnaround to $168M net profit for 2026. Recent developments include a strategic AI venture with Palantir and over $270M in new defense orders, boosting revenue visibility. Analyst sentiment is unanimously bullish with a consensus price target of $18.50.
The outlook for ONDS hinges on executing its growth strategy and achieving profitability targets. Investment opportunity lies in its expanding defense contracts and AI initiatives, but risks include persistent cash burn, high valuation multiples, and sector volatility. The stock presents a high-risk, high-reward profile dependent on successful operational execution and market adoption of its autonomous defense technologies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Ondas Inc. Common Stock
Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →
